Selected article for: "cc NC ND International license and infection control"
Author: Ru Liu; Xiaoyan Ming; Ou Xu; Jianli Zhou; Hui Peng; Ning Xiang; Jiaming Zhang; Hong Zhu
Title: Association of Cardiovascular Manifestations with In-hospital Outcomes in Patients with COVID-19: A Hospital Staff Data
  • Document date: 2020_3_3
    • ID: 9lissxsy_37
    Snippet: The analyzed population is characterized as younger age, less comorbidities than common community patients [11, 12] , and mostly featured non-severe course of There is no specific antiviral drug for SARS-CoV-2 infection up to now. Expectation mainly comes from evidences that remdesivir and chloroquine are highly effective in the control of 2019-nCoV infection in vitro, while their cytotoxicity remains in control [22] . It was reported that remdes.....
    Document: The analyzed population is characterized as younger age, less comorbidities than common community patients [11, 12] , and mostly featured non-severe course of There is no specific antiviral drug for SARS-CoV-2 infection up to now. Expectation mainly comes from evidences that remdesivir and chloroquine are highly effective in the control of 2019-nCoV infection in vitro, while their cytotoxicity remains in control [22] . It was reported that remdesivir, a nucleotide analogue prodrug, in previously clinical development for treatment of Ebola virus disease, exhibited broad-spectrum . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

    Search related documents:
    Co phrase search for related documents
    • analogue prodrug and broad spectrum: 1, 2, 3, 4, 5, 6, 7
    • analogue prodrug and cc NC ND International license: 1
    • analogue prodrug and Ebola virus: 1, 2, 3, 4
    • analogue prodrug and Ebola virus disease: 1
    • analogue prodrug and Ebola virus disease treatment: 1
    • analogue prodrug and International license: 1
    • analogue prodrug and nucleotide analogue prodrug: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • analogue prodrug and SARS infection: 1, 2, 3, 4, 5, 6, 7
    • analyze population and chloroquine remdesivir: 1
    • analyze population and SARS infection: 1, 2, 3, 4
    • antiviral drug and broad spectrum: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antiviral drug and cc NC ND International license: 1
    • antiviral drug and chloroquine remdesivir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • antiviral drug and community patient: 1, 2
    • antiviral drug and Ebola virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antiviral drug and Ebola virus disease: 1, 2, 3, 4, 5
    • antiviral drug and International license: 1, 2
    • antiviral drug and nucleotide analogue prodrug: 1
    • antiviral drug and SARS infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25